Nonalcoholic steatohepatitis (NASH) research at Mayo Clinic

Mayo Clinic researchers ask and answer fundamental questions about nonalcoholic steatohepatitis (NASH).

“Gut Touch” research and mechanistic pathways

Utilizing research to explore the concept of “gut touch,” Arthur Beyder, M.D., Ph.D., and Mayo Clinic GI researchers are identifying mechanistic pathways that are similar to other disease entities and collaborating with colleagues in other ...

GI division at Mayo Clinic Rochester leading innovation and change

The Rochester Gastroenterology and Hepatology Division succeeds through clinician-led innovation — recognizing gaps and finding solutions. Division leaders invest in the team, seeking opportunities to challenge that status quo, train the ...

Inflammatory bowel disease (IBD) research at Mayo Clinic

Mayo Clinic continues to explore frontiers in research, diagnostics, drug trials and treatment algorithms to advance IBD treatment and offer options to patients that change the course of their disease.

Endoscopic ultrasound (EUS)-guided pancreatic anti-tumoral therapy

Mayo Clinic gastroenterologist Michael J. Levy, M.D., discusses endoscopic ultrasound-guided pancreatic anti-tumoral therapy for the treatment of pancreatic masses.

Endoscopic ultrasound-guided angiotherapy

Michael J. Levy, M.D., a gastroenterologist at Mayo Clinic’s campus in Rochester, Minnesota, discusses endoscopic ultrasound (EUS)-guided angiotherapy for the treatment of gastrointestinal bleeding.